Physician profile
Jimmy E Couch
NPI 1932281904
$8,144.65
in general payments reported to CMS, 2019-2025
47 companies · $83.29 in 2025
The $83.29 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $3,142 · 2021: $922 · 2022: $1,265 · 2023: $1,724 · 2024: $60.07 · 2025: $83.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,658 · Education: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,657.83 |
| Education | $210.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $2,013.69 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Abbvie INC. | $1,358.14 | 2021-2025 | Ubrelvy, Botox, Qulipta |
| Allergan, INC. | $992.75 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $515.03 | 2019-2022 | |
| Pfizer INC. | $330.70 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $253.60 | 2019-2023 | |
| Alexion Pharmaceuticals, INC. | $233.40 | 2019-2023 | |
| Sunovion Pharmaceuticals INC. | $212.31 | 2019-2022 | |
| Emd Serono, INC. | $190.79 | 2019-2023 | Mavenclad |
| Biohaven Pharmaceutical Holding Company LTD. | $175.22 | 2022 | |
| Amgen INC. | $141.70 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $136.07 | 2019-2023 | Austedo Xr, Austedo |
| Avanir Pharmaceuticals, INC. | $135.27 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $119.70 | 2023 | Zeposia |
| Mallinckrodt Hospital Products INC. | $107.05 | 2021-2023 | Acthar |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jimmy Couch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.